
Journal of Organic Chemistry p. 4189 - 4195 (1986)
Update date:2022-08-05
Topics:
Parrinello, G.
Deschenaux, R.
Stille, J. K.
A chiral ligand, analogous to 2,3-O-isopropylidene-2,3-dihydroxy-1,4-bis(dibenzophospholyl)butane (DBP-DIOP) (5), attached to linear and to cross-linked polymer supports was obtained either by copolymerization of (4R,5R)-2-(p-styryl)-4,5-bis<(tosyloxy)methyl>-1,3-dioxolane (2) with styrene (or with styrene and divinylbenzene) followed by phosphination with lithium dibenzophosphole or directly by copolymerization of (4R,5R)-2-(p-styryl)-4,5-bis<(dibenzophospholyl)methyl>-1,3-dioxalane (4) with styrene (or with styrene and divinylbenzene).Exchange of Pt(II) onto the polymers followed by addition of stannous chloride gave polymer-supported catalysts which were used for asymmetric hydroformylation of a variety of olefins.Hydroformylations utilizing the polymer-supported catalysts showed comparable rates and gave nearly the same optical yields as the homogeneous analogue 5.However, lower branched to normal ratios were obtained from the polymer-supported catalysts, especially with those which were cross-linked.The soluble polymer-supported catalyst could be recovered by precipitation with diethyl ether and filtration.Reuse of this catalyst showed no loss in rate or selectivity.Recycling of the cross-linked polymer was achieved by simple filtration with slight loss in rate but no loss in selectivity.
View MoreContact:+44 (0)2036089360-31
Address:Chanceryhouse,Chancery Lan
Xinjiang Zhongtai Chemical Co., Ltd.
Contact:+86-991-8788172
Address:NO.78 XISHAN RD.URUMQI,CHINA
Beijing Zhongshuo Pharmaceutical T & D Co.,Ltd
Contact:0086-10-64430626
Address:ea No 16, HEPINGLI,DONGCHENG DISTRICT,BEIJING,P.R.CHINA.
Shanghai Yurui Biotechnology(Anyang) Pharmaceutical Co., Ltd
Contact:+86-0372-3662335 +86-0372-3661988
Address:hanling industrial park anyang
Suzhou Health Chemicals Co., Ltd.
website:http://www.healthchems.com
Contact:13776257979
Address:No. 338, Jingang Avenue,
Doi:10.1016/j.bmc.2009.01.056
(2009)Doi:10.1007/BF00947384
()Doi:10.1007/BF00539504
()Doi:10.1016/j.bmcl.2004.03.032
(2004)Doi:10.1039/c39790000079
(1979)Doi:10.1021/acsinfecdis.8b00272
(2019)